Effective treatment of advanced biliary tract carcinoma using 5-fluorouracil continuous infusion with cisplatin
Open Access
- 1 June 1998
- journal article
- clinical trial
- Published by Elsevier BV in Annals Of Oncology
- Vol. 9 (6), 653-656
- https://doi.org/10.1023/a:1008241008379
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer.Journal of Clinical Oncology, 1997
- Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancerAnnals Of Oncology, 1996
- Epirubicin, cisplatin and infusional 5-fluorouracil (5-FU) (ECF) in hepatobiliary tumoursEuropean Journal Of Cancer, 1995
- Epirubicin-Sequential Methotrexate-5-Fluorouracil-Leucovorin Treatment in Advanced Cancer of the Extrahepatic Biliary SystemAmerican Journal of Clinical Oncology, 1994
- Comparison of 5-Fluorouracil, Doxorubicin and Mitomycin C with 5-Fluorouracil Alone in the Treatment of Pancreatic-Biliary CarcinomasOncology, 1994
- A Phase II Study of Cisplatin in Patients with Biliary Tract CarcinomaOncology, 1994
- Phase II trial of mitomycin C (MMC) in advanced gallbladder and biliary tree carcinoma. An EORTC Gastrointestinal Tract Cancer Cooperative Group StudyAnnals Of Oncology, 1993
- Phase II study of cisplatin and 120-hour continuous infusion of 5-fluorouracil in patients with advanced pancreatic adenocarcinomaAnnals Of Oncology, 1993
- 5-Fluorouracil, mitomycin, and doxorubicin (FAM) in carcinoma of the biliary tract.Journal of Clinical Oncology, 1984
- Reporting results of cancer treatmentCancer, 1981